Xenetic Biosciences (XBIO) Analyst Estimates Annual - Discounting Cash Flows
Xenetic Biosciences, Inc.
XBIO (NASDAQ)

* (except for per share items) of USD
Period Ending: 2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
Number of Analysts 1 1 1 1 1 1 1 1 1
Estimated Revenue
Low 9.70 2.50 2.30 2.80 2.50 2.50 1.70 0.80 0.41
Average 9.70 2.50 2.30 2.80 2.50 2.50 1.70 0.80 0.41
High 9.70 2.50 2.30 2.80 2.50 2.50 1.70 0.80 0.41
Estimated EBITDA
Low -9.70 -2.50 -2.30 -2.80 -2.50 -2.50 -1.70 -0.48 -0.25
Average -9.70 -2.50 -2.30 -2.80 -2.50 -2.50 -1.70 -0.48 -0.25
High -9.70 -2.50 -2.30 -2.80 -2.50 -2.50 -1.70 -0.48 -0.25
Estimated EBIT
Low -9.70 -2.50 -2.30 -2.80 -2.50 -2.50 -1.70 -0.48 -0.25
Average -9.70 -2.50 -2.30 -2.80 -2.50 -2.50 -1.70 -0.48 -0.25
High -9.70 -2.50 -2.30 -2.80 -2.50 -2.50 -1.70 -0.48 -0.25
Estimated Net Income
Low -0.74 -0.83 -0.69 -4.99 -3.96 -1.06 -7.03 -8.41 -24.5
Average -0.74 -0.83 -0.69 -4.99 -3.96 -1.06 -7.03 -8.41 -24.5
High -0.74 -0.83 -0.69 -4.99 -3.96 -1.06 -7.03 -8.41 -24.5
Estimated SGA Expenses
Low 30.9 7.94 7.32 8.91 7.96 7.96 99.2 46.7 24.1
Average 30.9 7.96 7.32 8.91 7.96 7.96 99.2 46.7 24.1
High 30.9 7.97 7.32 8.91 7.96 7.96 99.2 46.7 24.1
Estimated EPS
Low -0.480 -0.540 -0.450 -3.240 -2.570 -0.690 -4.600 -5.500 -16.00
Average -0.480 -0.540 -0.450 -3.240 -2.570 -0.690 -4.600 -5.500 -16.00
High -0.480 -0.540 -0.450 -3.240 -2.570 -0.690 -4.600 -5.500 -16.00
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us